Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 plus cisplatin-based chemoradiotherapy after induction chemotherapy for locally advanced gastric adenocarcinoma (phase II)
KCT0003685Phase 2Completed
- Sponsor
- Boryung
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, cisplatin in gastric adenocarcinoma, sponsored by Boryung. Started Jan 2014; status: completed.
02
Drugs
tegafurcisplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on KCT0003685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003685.